Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus
出版年份 2021 全文链接
标题
Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus
作者
关键词
-
出版物
AMERICAN JOURNAL OF CARDIOLOGY
Volume 154, Issue -, Pages 48-53
出版商
Elsevier BV
发表日期
2021-07-12
DOI
10.1016/j.amjcard.2021.05.043
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis
- (2019) Fotios Barkas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
- (2018) María Isabel del Olmo-Garcia et al. Journal of Diabetes Research
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
- (2016) Abd A. Tahrani et al. Nature Reviews Endocrinology
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- How to read a Kaplan-Meier survival plot
- (2014) P. Sedgwick BMJ-British Medical Journal
- Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
- (2013) Craig J. Currie et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glycemic Control and Risk of Cardiovascular Disease Hospitalization and All-Cause Mortality
- (2013) Gregory A. Nichols et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
- (2011) K. L. Rensing et al. DIABETES OBESITY & METABOLISM
- A1C and Cardiovascular Outcomes in Type 2 Diabetes: A nested case-control study
- (2010) D. C. Colayco et al. DIABETES CARE
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Association between serious ischemic cardiac outcomes and medications used to treat diabetes
- (2008) David J. Margolis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started